IntelliSep检测作为急诊科疑似感染患者脓毒症诊断工具的评估
本研究在路易斯安那州巴吞鲁日两家急诊科前瞻性纳入266例成人疑似感染患者,以Sepsis-3标准经三级回顾性盲法裁定脓毒症状态。脓毒症患者IntelliSep指数中位数6.9(IQR 6.1-7.6),高于非脓毒症患者的4.7(IQR 3.7-5.9;p<0.001),与一致裁定和强制裁定标准比较的AUC分别为0.89和0.83。IntelliSep指数较高者SOFA评分(3 vs 1;p<0.001)、APACHE-II评分(7 vs 5;p<0.05)及住院率(83.6% vs 48.3%;p<0.001)均更高。结论认为IntelliSep指数是急诊科疑似感染患者脓毒症快速诊断和风险分层的 promising 工具。
要点
- 脓毒症患者IntelliSep指数中位数6.9(IQR 6.1-7.6),显著高于非脓毒症患者的4.7(IQR 3.7-5.9),p<0.001。
- IntelliSep指数诊断脓毒症的AUC为0.89(与一致裁定标准比较)和0.83(与强制裁定标准比较)。
- IntelliSep指数较高者SOFA评分中位数3(IQR 1-5)vs 1(IQR 0-2),p<0.001。
- IntelliSep指数较高者APACHE-II评分中位数7(IQR 3.5-11.5)vs 5(IQR 2-9),p<0.05。
- IntelliSep指数较高者住院率83.6% vs 48.3%,p<0.001。
适用人群与场景
- 就诊于路易斯安那州巴吞鲁日两家急诊科的成人患者。
- 纳入标准:有感染征象(4项全身炎症反应综合征标准中满足2项,且至少1项为体温或白细胞计数异常)或怀疑感染(临床医生开具体液培养医嘱)。
诊断标准与关键阈值
- 脓毒症诊断按Sepsis-3标准,通过三级回顾性盲法裁定流程确定:客观审查、站点临床医生审查、独立医师裁定者最终判定。
- IntelliSep检测为体外诊断,通过测量白细胞生物物理特性量化免疫激活状态。
研究设计与关键结果
- 研究类型:前瞻性纳入患者的诊断评估研究;最终分析266例。
- 脓毒症患者IntelliSep指数中位数6.9(IQR 6.1-7.6),非脓毒症患者4.7(IQR 3.7-5.9),p<0.001。
- IntelliSep指数诊断脓毒症的AUC为0.89(与一致裁定标准比较)和0.83(与强制裁定标准比较)。
- IntelliSep指数较高者SOFA评分中位数3(IQR 1-5)vs 较低者1(IQR 0-2),p<0.001。
- IntelliSep指数较高者APACHE-II评分中位数7(IQR 3.5-11.5)vs 较低者5(IQR 2-9),p<0.05。
- IntelliSep指数较高者住院率83.6% vs 较低者48.3%,p<0.001。
证据类型、等级与局限
- 证据类型:前瞻性诊断评估研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于急诊科有感染征象或怀疑感染的患者,IntelliSep指数是脓毒症快速诊断和风险分层的 promising 工具。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Sepsis is a common cause of morbidity and mortality. A reliable, rapid, and early indicator can help improve efficiency of care and outcomes. To assess the IntelliSep test, a novel in vitro diagnostic that quantifies the state of immune activation by measuring the biophysical properties of leukocytes, as a rapid diagnostic for sepsis and a measure of severity of illness, as defined by Sequential Organ Failure Assessment and Acute Physiology and Chronic Health Evaluation-II scores and the need for hospitalization.
DESIGN SETTING SUBJECTS: Adult patients presenting to two emergency departments in Baton Rouge, LA, with signs of infection (two of four systemic inflammatory response syndrome criteria, with at least one being aberration of temperature or WBC count) or suspicion of infection (a clinician order for culture of a body fluid), were prospectively enrolled. Sepsis status, per Sepsis-3 criteria, was determined through a 3-tiered retrospective and blinded adjudication process consisting of objective review, site-level clinician review, and final determination by independent physician adjudicators.
MEASUREMENTS AND MAIN RESULTS: Of 266 patients in the final analysis, those with sepsis had higher IntelliSep Index (median = 6.9; interquartile range, 6.1-7.6) than those adjudicated as not septic (median = 4.7; interquartile range, 3.7-5.9; p < 0.001), with an area under the receiver operating characteristic curve of 0.89 and 0.83 when compared with unanimous and forced adjudication standards, respectively. Patients with higher IntelliSep Index had higher Sequential Organ Failure Assessment (3 [interquartile range, 1-5] vs 1 [interquartile range, 0-2]; p < 0.001) and Acute Physiology and Chronic Health Evaluation-II (7 [interquartile range, 3.5-11.5] vs 5 [interquartile range, 2-9]; p < 0.05) and were more likely to be admitted to the hospital (83.6% vs 48.3%; p < 0.001) compared with those with lower IntelliSep Index.
CONCLUSIONS: In patients presenting to the emergency department with signs or suspicion of infection, the IntelliSep Index is a promising tool for the rapid diagnosis and risk stratification for sepsis.
参考来源
- O'Neal HR, Sheybani R, Caffery TS, et al. Assessment of a Cellular Host Response Test as a Sepsis Diagnostic for Those With Suspected Infection in the Emergency Department. Crit Care Explor. 2021. PMID: 34151282. doi:10.1097/CCE.0000000000000460
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。